Apimeds Pharmaceuticals US Inc
Research Apimeds Pharmaceuticals US Inc (APUS) on Bullrun: market cap USD 13.96M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAPUS
- ExchangeNYSE MKT
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 13.96M
- Financial periodFY2025
- Net income-USD 6.00M
- Free cash flow-USD 8.98M
Valuation Snapshot
latest market cap is USD 13.96M.
About Apimeds Pharmaceuticals US Inc
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Frequently asked questions
What is Apimeds Pharmaceuticals US Inc's market cap?
Apimeds Pharmaceuticals US Inc's market capitalization is USD 13.96M.
What does Apimeds Pharmaceuticals US Inc do?
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.